Generate a tailored SOP for Dr. Julia Tcw. Improve your application with a focused, well-structured draft.
Julia TCW received her Ph.D. in Molecular and Cellular Biology from Harvard University, focusing on induced pluripotent stem cell (iPSC) reprogramming. She completed her postdoctoral research in the Department of Neuroscience at the Ronald M. Loeb Center for Alzheimer’s Disease and the Department of Genetics and Genomic Sciences at Icahn School of Medicine at Mount Sinai. Her research primarily examines the genetics of Alzheimer’s disease (AD) through the development of iPSC models. The lab is dedicated to understanding how genetic variants, particularly Apolipoprotein E4 (APOE4), contribute to AD risk and pathophysiology. By utilizing forward genetics and multi-Omics approaches, her work seeks to uncover mechanisms and molecular pathways impacted by AD-related genetic factors. Furthermore, TCW's research involves developing innovative platforms for drug screening in human brain models to identify potential therapeutic targets for AD. She leads the Laboratory of Human Induced Pluripotent Stem Cell Therapeutics at Boston University and collaborates with various institutions and funding agencies to advance research in genetic influences on neurodegenerative diseases.
Department of Law offers JD, LLM, and Master's in Study of Tax Law.